Historical Valuation
Biohaven Ltd (BHVN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -4.29. The fair price of Biohaven Ltd (BHVN) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 11.11 USD , Biohaven Ltd is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：11.11
Fair
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Biohaven Ltd (BHVN) has a current Price-to-Book (P/B) ratio of -66.84. Compared to its 3-year average P/B ratio of 0.28 , the current P/B ratio is approximately -24016.82% higher. Relative to its 5-year average P/B ratio of 1.01, the current P/B ratio is about -6696.35% higher. Biohaven Ltd (BHVN) has a Forward Free Cash Flow (FCF) yield of approximately -45.21%. Compared to its 3-year average FCF yield of -22.88%, the current FCF yield is approximately 97.56% lower. Relative to its 5-year average FCF yield of -23.25% , the current FCF yield is about 94.45% lower.
P/B
Median3y
0.28
Median5y
1.01
FCF Yield
Median3y
-22.88
Median5y
-23.25
Competitors Valuation Multiple
AI Analysis for BHVN
The average P/S ratio for BHVN competitors is 110.75, providing a benchmark for relative valuation. Biohaven Ltd Corp (BHVN.N) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for BHVN
1Y
3Y
5Y
Market capitalization of BHVN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BHVN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is BHVN currently overvalued or undervalued?
Biohaven Ltd (BHVN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -4.29. The fair price of Biohaven Ltd (BHVN) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 11.11 USD , Biohaven Ltd is Undervalued By Fair .
What is Biohaven Ltd (BHVN) fair value?
BHVN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Biohaven Ltd (BHVN) is between +Inf to +Inf according to relative valuation methord.
How does BHVN's valuation metrics compare to the industry average?
The average P/S ratio for BHVN's competitors is 110.75, providing a benchmark for relative valuation. Biohaven Ltd Corp (BHVN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Biohaven Ltd (BHVN) as of Jan 11 2026?
As of Jan 11 2026, Biohaven Ltd (BHVN) has a P/B ratio of -66.84. This indicates that the market values BHVN at -66.84 times its book value.
What is the current FCF Yield for Biohaven Ltd (BHVN) as of Jan 11 2026?
As of Jan 11 2026, Biohaven Ltd (BHVN) has a FCF Yield of -45.21%. This means that for every dollar of Biohaven Ltd’s market capitalization, the company generates -45.21 cents in free cash flow.
What is the current Forward P/E ratio for Biohaven Ltd (BHVN) as of Jan 11 2026?
As of Jan 11 2026, Biohaven Ltd (BHVN) has a Forward P/E ratio of -2.51. This means the market is willing to pay $-2.51 for every dollar of Biohaven Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Biohaven Ltd (BHVN) as of Jan 11 2026?
As of Jan 11 2026, Biohaven Ltd (BHVN) has a Forward P/S ratio of 0.00. This means the market is valuing BHVN at $0.00 for every dollar of expected revenue over the next 12 months.